Your browser doesn't support javascript.
loading
Combining the pan-aurora kinase inhibitor AMG 900 with histone deacetylase inhibitors enhances antitumor activity in prostate cancer.
Paller, Channing J; Wissing, Michel D; Mendonca, Janet; Sharma, Anup; Kim, Eugene; Kim, Hea-Soo; Kortenhorst, Madeleine S Q; Gerber, Stephanie; Rosen, Marc; Shaikh, Faraz; Zahurak, Marianna L; Rudek, Michelle A; Hammers, Hans; Rudin, Charles M; Carducci, Michael A; Kachhap, Sushant K.
Affiliation
  • Paller CJ; Department of Oncology, The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins Medical Institutions, Baltimore, Maryland, 21231.
Cancer Med ; 3(5): 1322-35, 2014 Oct.
Article in En | MEDLINE | ID: mdl-24989836
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Phthalazines / Prostatic Neoplasms / Protein Kinase Inhibitors / Histone Deacetylase Inhibitors / Aurora Kinases Type of study: Prognostic_studies Limits: Animals / Humans / Male Language: En Journal: Cancer Med Year: 2014 Document type: Article Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Phthalazines / Prostatic Neoplasms / Protein Kinase Inhibitors / Histone Deacetylase Inhibitors / Aurora Kinases Type of study: Prognostic_studies Limits: Animals / Humans / Male Language: En Journal: Cancer Med Year: 2014 Document type: Article Country of publication: United States